MLL易位、组蛋白修饰与白血病干细胞发育
MLL translocations, histone modifications and leukaemia stem-cell development
原文发布日期:2007-11-01
DOI: 10.1038/nrc2253
类型: Review Article
开放获取: 否
要点:
要点翻译:
英文摘要:
摘要翻译:
原文链接:
Translocations that involve the mixed lineage leukaemia (MLL) gene identify a unique group of acute leukaemias, and often predict a poor prognosis. The MLL gene encodes a DNA-binding protein that methylates histone H3 lysine 4 (H3K4), and positively regulates gene expression including multiple Hox genes. Leukaemogenic MLL translocations encode MLL fusion proteins that have lost H3K4 methyltransferase activity. A key feature of MLL fusion proteins is their ability to efficiently transform haematopoietic cells into leukaemia stem cells. The link between a chromatin modulator and leukaemia stem cells provides support for epigenetic landscapes as an important part of leukaemia and normal stem-cell development.
涉及混合谱系白血病(MLL)基因的易位可识别出一类独特的急性白血病,且往往预示预后不良。MLL基因编码一种能与DNA结合的蛋白,该蛋白可使组蛋白H3第4位赖氨酸(H3K4)发生甲基化,从而正向调控包括多个Hox基因在内的基因表达。致病的MLL易位会产生MLL融合蛋白,这些蛋白丧失了H3K4甲基转移酶活性。MLL融合蛋白的一个关键特征是其能够高效地将造血细胞转化为白血病干细胞。染色质调节因子与白血病干细胞之间的联系支持了表观遗传景观是白血病及正常干细胞发育的重要组成部分。
MLL translocations, histone modifications and leukaemia stem-cell development
……